LATEST NEWS
Oxford Vacmedix announce successful Phase 1 trial results for cancer
23 . 04 . 26
Oxford Vacmedix , a biotech company developing novel immunotherapies to treat cancer, has announced the successful completion of the Phase 1 trial of OVM-200.
The primary endpoint for safety has been met as well as the secondary endpoints for...
Read More